Skip to main content
logo
LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
4.290
+0.790 (22.57%)
At close: Nov 9, 2026, 4:00 PM EST
4.295
+0.005 (0.11%)
Pre-market: Nov 10, 2026, 6:32 AM EST

LENZ Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12.3619.09--15-
Revenue Growth
-29.38%-----
Gross Profit
10.1318.67--15-
Operating Income
-149.69-91.14-58.61-72.43-10.48-6.69
Net Income
-140.27-82.13-49.77-69.97-10.81-7.56
Earnings Per Share
-4.48-2.85-2.34-35.71-1.14-0.81
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
197.3292.35209.0365.7944.4418.31
Total Debt
0.460.821.380.330.25-
Net Cash (Debt)
196.84291.53207.6565.4744.1918.31
Net Cash Growth
-2.17%40.40%217.19%48.14%141.39%-
Net Cash Per Share
6.2910.129.7633.424.671.96

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-127.63-69.17-59.39-60.38-4.09-5.39
Capital Expenditures
-0.07-0.83-0.47-0.03-0.04-0.01
Free Cash Flow
-127.7-70-59.86-60.41-4.13-5.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
81.97%97.81%--100.00%-
Operating Margin
-1211.17%-477.46%---69.89%-
Pretax Margin
-1134.93%-427.62%---69.76%-
Profit Margin
-1134.97%-430.25%---72.07%-
FCF Margin
-1033.28%-366.71%---27.52%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.9126.23----